Outcome MeasureAnxiety

Y-BOCS

Yale-Brown Obsessive Compulsive Scale

5 Papers in Blossom

About This Instrument

The Yale-Brown Obsessive Compulsive Scale (Y-BOCS) is a 10-item clinician-administered rating scale considered the gold standard for measuring the severity of obsessive-compulsive disorder symptoms. Five items assess obsessions and five assess compulsions, each rated 0–4 on dimensions of time occupied, interference, distress, resistance, and degree of control. Total scores range from 0 to 40. The Y-BOCS is the primary endpoint in psilocybin-for-OCD research, including the pioneering study by Francisco Moreno at the University of Arizona (2006) and ongoing trials at Yale University. Those studies demonstrated significant acute reductions in Y-BOCS scores following psilocybin administration. A 35% or greater reduction from baseline is typically considered a clinically meaningful response. The Y-BOCS has excellent interrater reliability (ICC > 0.90) and is sensitive to treatment-related change.

Clinical Thresholds

040
Subclinical
Score 07
Mild
Score 815
Moderate
Score 1623
Severe
Score 2431
Extreme
Score 3240

Outcome Data Across Studies

Reported results for Y-BOCS across 4 studies with quantitative data.

Outcome data across 42 study arm–timepoint observations
SD
Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder
2006Secondary
Very Low Dose (VLD)(experimental)0718.3
Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder
2006Secondary
Very Low Dose (VLD)(experimental)24711.1
Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder
2006Secondary
Low Dose (LD)(experimental)0924.1
Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder
2006Secondary
Low Dose (LD)(experimental)24910.7
Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder
2006Secondary
Medium Dose (MD)(experimental)0719.6
Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder
2006Secondary
Medium Dose (MD)(experimental)24711.0
Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder
2006Secondary
High Dose (HD)(experimental)0618.8
Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder
2006Secondary
High Dose (HD)(experimental)24611.3
Ketamine for treatment-resistant obsessive-compulsive disorder: Double-blind active-controlled crossover study
2024Primary
Experimental Arm(experimental)01029.93.9
Ketamine for treatment-resistant obsessive-compulsive disorder: Double-blind active-controlled crossover study
2024Primary
Experimental Arm(experimental)11014.9

Papers Using Y-BOCS

Quick Facts

Full Name
Yale-Brown Obsessive Compulsive Scale
Domain
Anxiety
Papers Indexed
5
Score Range
040
Interpretation
Lower = better
Unit
points
All Measures